168 related articles for article (PubMed ID: 36472871)
41. Update of Incidence, Prevalence, Survival, and Initial Treatment in Patients With Non-Small Cell Lung Cancer in the US.
Ganti AK; Klein AB; Cotarla I; Seal B; Chou E
JAMA Oncol; 2021 Dec; 7(12):1824-1832. PubMed ID: 34673888
[TBL] [Abstract][Full Text] [Related]
42. Spending by the Centers for Medicare & Medicaid Services Before and After Confirmation of Benefit for Drugs Granted US Food and Drug Administration Accelerated Approval, 2012 to 2017.
Skydel JJ; Egilman AC; Wallach JD; Ramachandran R; Gupta R; Ross JS
JAMA Health Forum; 2022 May; 3(5):e221158. PubMed ID: 35977252
[TBL] [Abstract][Full Text] [Related]
43. Incidence of childhood and adolescent melanoma in the United States: 1973-2009.
Wong JR; Harris JK; Rodriguez-Galindo C; Johnson KJ
Pediatrics; 2013 May; 131(5):846-54. PubMed ID: 23589817
[TBL] [Abstract][Full Text] [Related]
44. Use of Extrapolation in New Drug Approvals by the US Food and Drug Administration.
Feldman D; Avorn J; Kesselheim AS
JAMA Netw Open; 2022 Apr; 5(4):e227958. PubMed ID: 35438753
[TBL] [Abstract][Full Text] [Related]
45. Completion Rate and Reporting of Mandatory Pediatric Postmarketing Studies Under the US Pediatric Research Equity Act.
Hwang TJ; Orenstein L; Kesselheim AS; Bourgeois FT
JAMA Pediatr; 2019 Jan; 173(1):68-74. PubMed ID: 30452498
[TBL] [Abstract][Full Text] [Related]
46. Postmarket Safety Events Among Novel Therapeutics Approved by the US Food and Drug Administration Between 2001 and 2010.
Downing NS; Shah ND; Aminawung JA; Pease AM; Zeitoun JD; Krumholz HM; Ross JS
JAMA; 2017 May; 317(18):1854-1863. PubMed ID: 28492899
[TBL] [Abstract][Full Text] [Related]
47. Thyroid Cancer Incidence and Mortality Trends in the United States: 2000-2018.
Megwalu UC; Moon PK
Thyroid; 2022 May; 32(5):560-570. PubMed ID: 35132899
[No Abstract] [Full Text] [Related]
48. Uveal melanoma: trends in incidence, treatment, and survival.
Singh AD; Turell ME; Topham AK
Ophthalmology; 2011 Sep; 118(9):1881-5. PubMed ID: 21704381
[TBL] [Abstract][Full Text] [Related]
49. Recent Trends in Synchronous Brain Metastasis Incidence and Mortality in the United States: Ten-Year Multicenter Experience.
Che W; Liu J; Fu T; Wang X; Lyu J
Curr Oncol; 2022 Nov; 29(11):8374-8389. PubMed ID: 36354720
[TBL] [Abstract][Full Text] [Related]
50. Trends in Human Papillomavirus-Associated Cancers, Demographic Characteristics, and Vaccinations in the US, 2001-2017.
Liao CI; Francoeur AA; Kapp DS; Caesar MAP; Huh WK; Chan JK
JAMA Netw Open; 2022 Mar; 5(3):e222530. PubMed ID: 35294540
[TBL] [Abstract][Full Text] [Related]
51. Assessment of Trends in Second Primary Cancers in Patients With Metastatic Melanoma From 2005 to 2016.
Deng W; Wang Y; Liu X; Liu J; Wang L; Yang Z; Yang M; An Y; Tang C; Sanford NN; Kim BYS; Jiang W
JAMA Netw Open; 2020 Dec; 3(12):e2028627. PubMed ID: 33295975
[TBL] [Abstract][Full Text] [Related]
52. Association of the USPSTF Grade D Recommendation Against Prostate-Specific Antigen Screening With Prostate Cancer-Specific Mortality.
Burgess L; Aldrighetti CM; Ghosh A; Niemierko A; Chino F; Huynh MJ; Efstathiou JA; Kamran SC
JAMA Netw Open; 2022 May; 5(5):e2211869. PubMed ID: 35576008
[TBL] [Abstract][Full Text] [Related]
53. Trends in incidence of primary cutaneous malignancies in children, adolescents, and young adults: a population-based study.
Senerchia AA; Ribeiro KB; Rodriguez-Galindo C
Pediatr Blood Cancer; 2014 Feb; 61(2):211-6. PubMed ID: 24174376
[TBL] [Abstract][Full Text] [Related]
54. Temporal Trends in Opioid Prescribing Practices in Children, Adolescents, and Younger Adults in the US From 2006 to 2018.
Renny MH; Yin HS; Jent V; Hadland SE; Cerdá M
JAMA Pediatr; 2021 Oct; 175(10):1043-1052. PubMed ID: 34180978
[TBL] [Abstract][Full Text] [Related]
55. Descriptive epidemiology of pituitary tumors in the United States, 2004-2009.
Gittleman H; Ostrom QT; Farah PD; Ondracek A; Chen Y; Wolinsky Y; Kruchko C; Singer J; Kshettry VR; Laws ER; Sloan AE; Selman WR; Barnholtz-Sloan JS
J Neurosurg; 2014 Sep; 121(3):527-35. PubMed ID: 24926650
[TBL] [Abstract][Full Text] [Related]
56. Political environment and mortality rates in the United States, 2001-19: population based cross sectional analysis.
Warraich HJ; Kumar P; Nasir K; Joynt Maddox KE; Wadhera RK
BMJ; 2022 Jun; 377():e069308. PubMed ID: 35672032
[TBL] [Abstract][Full Text] [Related]
57. Melanoma Vaccine--AVAX Technologies: DNP-VACC, M-Vax.
BioDrugs; 2003; 17(1):69-72. PubMed ID: 12534322
[TBL] [Abstract][Full Text] [Related]
58. Has Stage Migration in Renal Cancer Run Its Course? A SEER Database Analysis.
Haifler M; Neheman A; Zisman A
Clin Genitourin Cancer; 2020 Aug; 18(4):e368-e373. PubMed ID: 32089472
[TBL] [Abstract][Full Text] [Related]
59. Changes in mortality associated with cancer drug approvals in the United States from 2000 to 2016.
MacEwan JP; Dennen S; Kee R; Ali F; Shafrin J; Batt K
J Med Econ; 2020 Dec; 23(12):1558-1569. PubMed ID: 33161782
[TBL] [Abstract][Full Text] [Related]
60. Assessment of Outcomes Associated With the Use of Newly Approved Oncology Drugs in Medicare Beneficiaries.
Green AK; Curry M; Trivedi N; Bach PB; Mailankody S
JAMA Netw Open; 2021 Feb; 4(2):e210030. PubMed ID: 33625507
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
